Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States.

Tamma PD, Sharara SL, Pana ZD, Amoah J, Fisher SL, Tekle T, Doi Y, Simner PJ.

Open Forum Infect Dis. 2019 Aug 11;6(8):ofz353. doi: 10.1093/ofid/ofz353.

2.

Conservation of the structure and function of bacterial tryptophan synthases.

Michalska K, Gale J, Joachimiak G, Chang C, Hatzos-Skintges C, Nocek B, Johnston SE, Bigelow L, Bajrami B, Jedrzejczak RP, Wellington S, Hung DT, Nag PP, Fisher SL, Endres M, Joachimiak A.

IUCrJ. 2019 May 29;6(Pt 4):649-664. doi: 10.1107/S2052252519005955. eCollection 2019 Jul 1.

3.

Nanoporous aramid nanofibre separators for nonaqueous redox flow batteries.

Tung SO, Fisher SL, Kotov NA, Thompson LT.

Nat Commun. 2018 Oct 10;9(1):4193. doi: 10.1038/s41467-018-05752-x.

4.

E-cigarette Usage Is Associated With Increased Past-12-Month Quit Attempts and Successful Smoking Cessation in Two US Population-Based Surveys.

Johnson L, Ma Y, Fisher SL, Ramsey AT, Chen LS, Hartz SM, Culverhouse RC, Grucza RA, Saccone NL, Baker TB, Bierut LJ.

Nicotine Tob Res. 2019 Sep 19;21(10):1331-1338. doi: 10.1093/ntr/nty211.

5.

Daily Drinking Is Associated with Increased Mortality.

Hartz SM, Oehlert M, Horton AC, Grucza RA, Fisher SL, Culverhouse RC, Nelson KG, Sumerall SW, Neal PC, Regnier P, Chen G, Williams A, Bhattarai J, Evanoff B, Bierut LJ.

Alcohol Clin Exp Res. 2018 Nov;42(11):2246-2255. doi: 10.1111/acer.13886. Epub 2018 Oct 3.

6.

Targeted protein degradation and the enzymology of degraders.

Fisher SL, Phillips AJ.

Curr Opin Chem Biol. 2018 Jun;44:47-55. doi: 10.1016/j.cbpa.2018.05.004. Epub 2018 Jun 7. Review.

PMID:
29885948
7.

Tobacco Use Prevalence and Smoking Cessation Pharmacotherapy Prescription Patterns Among Hospitalized Patients by Medical Specialty.

Srivastava AB, Ramsey AT, McIntosh LD, Bailey TC, Fisher SL, Fox L, Castro M, Ma Y, Baker TB, Chen LS, Bierut LJ.

Nicotine Tob Res. 2019 Apr 17;21(5):631-637. doi: 10.1093/ntr/nty031.

8.

Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.

Ramsey AT, Chen LS, Hartz SM, Saccone NL, Fisher SL, Proctor EK, Bierut LJ.

Transl Behav Med. 2018 Jan 29;8(1):7-17. doi: 10.1093/tbm/ibx060. Review.

9.

A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase.

Wellington S, Nag PP, Michalska K, Johnston SE, Jedrzejczak RP, Kaushik VK, Clatworthy AE, Siddiqi N, McCarren P, Bajrami B, Maltseva NI, Combs S, Fisher SL, Joachimiak A, Schreiber SL, Hung DT.

Nat Chem Biol. 2017 Sep;13(9):943-950. doi: 10.1038/nchembio.2420. Epub 2017 Jul 3.

10.

A quantitative mechanistic PK/PD model directly connects Btk target engagement and in vivo efficacy.

Daryaee F, Zhang Z, Gogarty KR, Li Y, Merino J, Fisher SL, Tonge PJ.

Chem Sci. 2017 May 1;8(5):3434-3443. doi: 10.1039/c6sc03306g. Epub 2017 Mar 14.

11.

Feasibility of a Supporting-Salt-Free Nonaqueous Redox Flow Battery Utilizing Ionic Active Materials.

Milshtein JD, Fisher SL, Breault TM, Thompson LT, Brushett FR.

ChemSusChem. 2017 May 9;10(9):2080-2088. doi: 10.1002/cssc.201700028. Epub 2017 Mar 30.

12.

Mechanism-Based Development of a Low-Potential, Soluble, and Cyclable Multielectron Anolyte for Nonaqueous Redox Flow Batteries.

Sevov CS, Fisher SL, Thompson LT, Sanford MS.

J Am Chem Soc. 2016 Nov 30;138(47):15378-15384. Epub 2016 Nov 15.

PMID:
27933936
13.

Correlating Drug-Target Kinetics and In vivo Pharmacodynamics: Long Residence Time Inhibitors of the FabI Enoyl-ACP Reductase.

Daryaee F, Chang A, Schiebel J, Lu Y, Zhang Z, Kapilashrami K, Walker SG, Kisker C, Sotriffer CA, Fisher SL, Tonge PJ.

Chem Sci. 2016 Sep 1;7(9):5945-5954. Epub 2016 May 25.

14.

The significant impact of education, poverty, and race on Internet-based research participant engagement.

Hartz SM, Quan T, Ibiebele A, Fisher SL, Olfson E, Salyer P, Bierut LJ.

Genet Med. 2017 Feb;19(2):240-243. doi: 10.1038/gim.2016.91. Epub 2016 Jul 28.

15.

Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors.

Wagner FF, Weïwer M, Steinbacher S, Schomburg A, Reinemer P, Gale JP, Campbell AJ, Fisher SL, Zhao WN, Reis SA, Hennig KM, Thomas M, Müller P, Jefson MR, Fass DM, Haggarty SJ, Zhang YL, Holson EB.

Bioorg Med Chem. 2016 Sep 15;24(18):4008-4015. doi: 10.1016/j.bmc.2016.06.040. Epub 2016 Jun 22.

PMID:
27377864
16.

An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection.

Wagner FF, Lundh M, Kaya T, McCarren P, Zhang YL, Chattopadhyay S, Gale JP, Galbo T, Fisher SL, Meier BC, Vetere A, Richardson S, Morgan NG, Christensen DP, Gilbert TJ, Hooker JM, Leroy M, Walpita D, Mandrup-Poulsen T, Wagner BK, Holson EB.

ACS Chem Biol. 2016 Feb 19;11(2):363-74. doi: 10.1021/acschembio.5b00640. Epub 2015 Dec 7.

PMID:
26640968
17.

Novel broad-spectrum inhibitors of bacterial methionine aminopeptidase.

Rose JA, Lahiri SD, McKinney DC, Albert R, Morningstar ML, Shapiro AB, Fisher SL, Fleming PR.

Bioorg Med Chem Lett. 2015 Aug 15;25(16):3301-6. doi: 10.1016/j.bmcl.2015.05.061. Epub 2015 May 30.

PMID:
26099541
18.

Translating slow-binding inhibition kinetics into cellular and in vivo effects.

Walkup GK, You Z, Ross PL, Allen EK, Daryaee F, Hale MR, O'Donnell J, Ehmann DE, Schuck VJ, Buurman ET, Choy AL, Hajec L, Murphy-Benenato K, Marone V, Patey SA, Grosser LA, Johnstone M, Walker SG, Tonge PJ, Fisher SL.

Nat Chem Biol. 2015 Jun;11(6):416-23. doi: 10.1038/nchembio.1796. Epub 2015 Apr 20.

19.

Kinetically Selective Inhibitors of Histone Deacetylase 2 (HDAC2) as Cognition Enhancers.

Wagner FF, Zhang YL, Fass DM, Joseph N, Gale JP, Weïwer M, McCarren P, Fisher SL, Kaya T, Zhao WN, Reis SA, Hennig KM, Thomas M, Lemercier BC, Lewis MC, Guan JS, Moyer MP, Scolnick E, Haggarty SJ, Tsai LH, Holson EB.

Chem Sci. 2015 Jan 1;6(1):804-815.

20.

Twitter chatter about marijuana.

Cavazos-Rehg PA, Krauss M, Fisher SL, Salyer P, Grucza RA, Bierut LJ.

J Adolesc Health. 2015 Feb;56(2):139-45. doi: 10.1016/j.jadohealth.2014.10.270.

21.

Simplified microarray system for simultaneously detecting rifampin, isoniazid, ethambutol, and streptomycin resistance markers in Mycobacterium tuberculosis.

Linger Y, Kukhtin A, Golova J, Perov A, Lambarqui A, Bryant L, Rudy GB, Dionne K, Fisher SL, Parrish N, Chandler DP.

J Clin Microbiol. 2014 Jun;52(6):2100-7. doi: 10.1128/JCM.00238-14. Epub 2014 Apr 9.

22.

Secreted Gaussia princeps luciferase as a reporter of Escherichia coli replication in a mouse tissue cage model of infection.

Liu M, Blinn C, McLeod SM, Wiseman JW, Newman JV, Fisher SL, Walkup GK.

PLoS One. 2014 Mar 4;9(3):e90382. doi: 10.1371/journal.pone.0090382. eCollection 2014.

23.

Kinetics of avibactam inhibition against Class A, C, and D β-lactamases.

Ehmann DE, Jahic H, Ross PL, Gu RF, Hu J, Durand-Réville TF, Lahiri S, Thresher J, Livchak S, Gao N, Palmer T, Walkup GK, Fisher SL.

J Biol Chem. 2013 Sep 27;288(39):27960-71. doi: 10.1074/jbc.M113.485979. Epub 2013 Aug 2.

24.

Association of adiposity genetic variants with menarche timing in 92,105 women of European descent.

Fernández-Rhodes L, Demerath EW, Cousminer DL, Tao R, Dreyfus JG, Esko T, Smith AV, Gudnason V, Harris TB, Launer L, McArdle PF, Yerges-Armstrong LM, Elks CE, Strachan DP, Kutalik Z, Vollenweider P, Feenstra B, Boyd HA, Metspalu A, Mihailov E, Broer L, Zillikens MC, Oostra B, van Duijn CM, Lunetta KL, Perry JR, Murray A, Koller DL, Lai D, Corre T, Toniolo D, Albrecht E, Stöckl D, Grallert H, Gieger C, Hayward C, Polasek O, Rudan I, Wilson JF, He C, Kraft P, Hu FB, Hunter DJ, Hottenga JJ, Willemsen G, Boomsma DI, Byrne EM, Martin NG, Montgomery GW, Warrington NM, Pennell CE, Stolk L, Visser JA, Hofman A, Uitterlinden AG, Rivadeneira F, Lin P, Fisher SL, Bierut LJ, Crisponi L, Porcu E, Mangino M, Zhai G, Spector TD, Buring JE, Rose LM, Ridker PM, Poole C, Hirschhorn JN, Murabito JM, Chasman DI, Widen E, North KE, Ong KK, Franceschini N.

Am J Epidemiol. 2013 Aug 1;178(3):451-60. doi: 10.1093/aje/kws473. Epub 2013 Apr 4.

25.

Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile.

Reck F, Alm RA, Brassil P, Newman JV, Ciaccio P, McNulty J, Barthlow H, Goteti K, Breen J, Comita-Prevoir J, Cronin M, Ehmann DE, Geng B, Godfrey AA, Fisher SL.

J Med Chem. 2012 Aug 9;55(15):6916-33. doi: 10.1021/jm300690s. Epub 2012 Jul 20.

PMID:
22779424
26.

Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor.

Ehmann DE, Jahić H, Ross PL, Gu RF, Hu J, Kern G, Walkup GK, Fisher SL.

Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11663-8. doi: 10.1073/pnas.1205073109. Epub 2012 Jul 2.

27.

Sextuplet heterotopic pregnancy presenting as ovarian hyperstimulation syndrome and hemoperitoneum.

Fisher SL, Massie JA, Blumenfeld YJ, Lathi RB.

Fertil Steril. 2011 Jun;95(7):2431.e1-3. doi: 10.1016/j.fertnstert.2011.01.172. Epub 2011 Mar 15.

PMID:
21406303
28.

The effect of air bubble position after blastocyst transfer on pregnancy rates in IVF cycles.

Friedman BE, Lathi RB, Henne MB, Fisher SL, Milki AA.

Fertil Steril. 2011 Mar 1;95(3):944-7. doi: 10.1016/j.fertnstert.2010.07.1063.

PMID:
20810105
29.

Power to the people: using learner control to improve trainee reactions and learning in web-based instructional environments.

Orvis KA, Fisher SL, Wasserman ME.

J Appl Psychol. 2009 Jul;94(4):960-71. doi: 10.1037/a0014977.

PMID:
19594237
30.

Glutamate racemase as a target for drug discovery.

Fisher SL.

Microb Biotechnol. 2008 Sep;1(5):345-60. doi: 10.1111/j.1751-7915.2008.00031.x. Epub 2008 May 11. Review.

31.

How implicitly activated and explicitly acquired knowledge contribute to the effectiveness of retrieval cues.

Nelson DL, Fisher SL, Akirmak U.

Mem Cognit. 2007 Dec;35(8):1892-904.

PMID:
18265606
32.

Exploitation of structural and regulatory diversity in glutamate racemases.

Lundqvist T, Fisher SL, Kern G, Folmer RH, Xue Y, Newton DT, Keating TA, Alm RA, de Jonge BL.

Nature. 2007 Jun 14;447(7146):817-22.

PMID:
17568739
33.

Teenagers are right--parents do not know much: an analysis of adolescent-parent agreement on reports of adolescent substance use, abuse, and dependence.

Fisher SL, Bucholz KK, Reich W, Fox L, Kuperman S, Kramer J, Hesselbrock V, Dick DM, Nurnberger JI Jr, Edenberg HJ, Bierut LJ.

Alcohol Clin Exp Res. 2006 Oct;30(10):1699-710.

PMID:
17010137
35.

Five-year surveillance of West Nile and eastern equine encephalitis viruses in Southeastern Virginia.

Loftin KC, Diallo AA, Herbert MW, Phaltankar PG, Yuan C, Grefe N, Flemming A, Foley K, Williams J, Fisher SL, Elberfeld M, Constantine J, Burcham M, Stallings V, Xia D.

J Environ Health. 2006 May;68(9):33-40.

PMID:
16696451
36.

Development of an LC-MS based enzyme activity assay for MurC: application to evaluation of inhibitors and kinetic analysis.

Deng G, Gu RF, Marmor S, Fisher SL, Jahic H, Sanyal G.

J Pharm Biomed Anal. 2004 Jun 29;35(4):817-28.

PMID:
15193726
37.

Biochemical characterization of an inhibitor of Escherichia coli UDP-N-acetylmuramyl-l-alanine ligase.

Ehmann DE, Demeritt JE, Hull KG, Fisher SL.

Biochim Biophys Acta. 2004 May 6;1698(2):167-74.

PMID:
15134649
38.

Biochemical characterization of a phosphinate inhibitor of Escherichia coli MurC.

Marmor S, Petersen CP, Reck F, Yang W, Gao N, Fisher SL.

Biochemistry. 2001 Oct 9;40(40):12207-14.

PMID:
11580296
39.

Melanocortin-4 receptor: a novel signalling pathway involved in body weight regulation.

Fisher SL, Yagaloff KA, Burn P.

Int J Obes Relat Metab Disord. 1999 Feb;23 Suppl 1:54-8. Review.

PMID:
10193863
40.

Identification and functional analysis of novel human melanocortin-4 receptor variants.

Gu W, Tu Z, Kleyn PW, Kissebah A, Duprat L, Lee J, Chin W, Maruti S, Deng N, Fisher SL, Franco LS, Burn P, Yagaloff KA, Nathan J, Heymsfield S, Albu J, Pi-Sunyer FX, Allison DB.

Diabetes. 1999 Mar;48(3):635-9.

PMID:
10078568
41.

Melanocortin and leptin signaling systems: central regulation of catabolic energy balance.

Fisher SL, Yagaloff KA, Burn P.

J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):203-16. Review.

PMID:
10071759
42.

Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.

Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Burn P, Palmiter RD.

Nat Genet. 1999 Jan;21(1):119-22.

PMID:
9916804
43.

The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling.

Zeng W, Xu X, Popov S, Mukhopadhyay S, Chidiac P, Swistok J, Danho W, Yagaloff KA, Fisher SL, Ross EM, Muallem S, Wilkie TM.

J Biol Chem. 1998 Dec 25;273(52):34687-90.

44.

Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion.

Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ.

Am J Physiol. 1998 Jan;274(1):R248-54. doi: 10.1152/ajpregu.1998.274.1.R248.

PMID:
9458925
45.

Melanocortin receptors in leptin effects.

Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW.

Nature. 1997 Nov 27;390(6658):349. No abstract available.

PMID:
9389472
47.

Altered recognition mutants of the response regulator PhoB: a new genetic strategy for studying protein-protein interactions.

Haldimann A, Prahalad MK, Fisher SL, Kim SK, Walsh CT, Wanner BL.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14361-6.

48.

Kinetic comparison of the specificity of the vancomycin resistance VanSfor two response regulators, VanR and PhoB.

Fisher SL, Kim SK, Wanner BL, Walsh CT.

Biochemistry. 1996 Apr 16;35(15):4732-40.

PMID:
8664263
49.

Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story.

Walsh CT, Fisher SL, Park IS, Prahalad M, Wu Z.

Chem Biol. 1996 Jan;3(1):21-8. Review.

Supplemental Content

Loading ...
Support Center